Howard Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$304K Buy
12,628
+1,539
+14% +$40.3K 0.03% 187
2026
Q1
$311K Buy
11,089
+301
+3% +$8.01K 0.04% 167
2025
Q4
$269K Buy
+10,788
New +$272K 0.03% 167
2025
Q1
Sell
-11,922
Closed -$316K 191
2024
Q4
$316K Sell
11,922
-1,299
-10% -$35.2K 0.04% 140
2024
Q3
$383K Buy
13,221
+511
+4% +$14.9K 0.06% 110
2024
Q2
$356K Buy
12,710
+156
+1% +$4.29K 0.06% 108
2024
Q1
$348K Buy
12,554
+495
+4% +$13.7K 0.06% 111
2023
Q4
$347K Buy
+12,059
New +$365K 0.07% 111
2023
Q3
Sell
-5,779
Closed -$212K 154
2023
Q2
$212K Sell
5,779
-6
-0.1% -$234 0.05% 129
2023
Q1
$236K Buy
5,785
+1,393
+32% +$60.2K 0.06% 120
2022
Q4
$225K Buy
+4,392
New +$211K 0.06% 121
2022
Q1
Sell
-4,616
Closed -$273K 147
2021
Q4
$273K Buy
+4,616
New +$229K 0.08% 99

Other funds holding PFE

Howard Financial Services's PFE Position: Q2 2026 in Review

Howard Financial Services increased its Pfizer (PFE) stake by 14% in Q2 2026, buying an estimated $40.3K and bringing the position to 12,628 shares worth $304K. The position accounts for 0.03% of the portfolio, ranked #187.

Howard Financial Services first reported a position in PFE in Q4 2021 and has held it in 12 quarters since. The position peaked at $383K in Q3 2024. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Howard Financial Services held 12,628 shares of Pfizer worth $304K as of Q2 2026.
  • Howard Financial Services bought 1,539 Pfizer shares in Q2 2026, an estimated $40.3K.
  • Pfizer made up 0.03% of Howard Financial Services's portfolio in Q2 2026, its #187 holding.
  • Howard Financial Services first reported a position in Pfizer in Q4 2021 and has held it in 12 quarters since.
  • Howard Financial Services's Pfizer position peaked at $383K in Q3 2024.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Howard Financial Services's 13F filing for Q2 2026, filed 7 Jul 2026.